Rad51 Expression Is a Useful Predictive Factor for the Efficacy of Neoadjuvant Chemoradiotherapy in Squamous Cell Carcinoma of the Esophagus

Tomonori Nakanoko; Hiroshi Saeki; Masaru Morita; Yuichiro Nakashima; Koji Ando; Eiji Oki; Takefumi Ohga; Yoshihiro Kakeji; Yasushi Toh; Yoshihiko Maehara

doi:10.1245/s10434-013-3220-2

Rad51 Expression Is a Useful Predictive Factor for the Efficacy of Neoadjuvant Chemoradiotherapy in Squamous Cell Carcinoma of the Esophagus

By Tomonori Nakanoko, Hiroshi Saeki, Masaru Morita, Yuichiro Nakashima, Koji Ando, Eiji Oki, Takefumi Ohga, Yoshihiro Kakeji, Yasushi Toh and Yoshihiko Maehara

Publisher: Springer Nature

Year: 2013

DOI identifier: 10.1245/s10434-013-3220-2

OAI identifier:

Provided by: MUCC (Crossref)

Download PDF:
_{Sorry, we are unable to provide the full text but you may find it at the
following location(s):}

https://link.springer.com/cont... (external link)

http://link.springer.com/conte... (external link)

Rad51 Expression Is a Useful Predictive Factor for the Efficacy of Neoadjuvant Chemoradiotherapy in Squamous Cell Carcinoma of the Esophagus

Suggested articles